Y Intercept Hong Kong Ltd Purchases Shares of 9,173 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Y Intercept Hong Kong Ltd bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 9,173 shares of the medical equipment provider's stock, valued at approximately $4,543,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Hurley Capital LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth $28,000. Parvin Asset Management LLC bought a new stake in Intuitive Surgical during the fourth quarter worth approximately $26,000. Chilton Capital Management LLC raised its position in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares during the period. Global Financial Private Client LLC lifted its holdings in shares of Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after acquiring an additional 38 shares during the last quarter. Finally, Elite Financial Inc. bought a new position in shares of Intuitive Surgical during the first quarter valued at approximately $26,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG stock traded up $4.51 during midday trading on Friday, hitting $493.12. The company had a trading volume of 878,178 shares, compared to its average volume of 1,986,628. The stock has a market cap of $176.74 billion, a price-to-earnings ratio of 68.76, a PEG ratio of 5.32 and a beta of 1.64. The company's 50 day simple moving average is $531.22 and its 200 day simple moving average is $535.38. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. Intuitive Surgical's quarterly revenue was up 21.4% on a year-over-year basis. During the same period last year, the firm posted $1.78 EPS. Analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity

In other news, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president owned 907 shares in the company, valued at $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $515.91, for a total value of $96,991.08. Following the transaction, the executive vice president owned 5,224 shares of the company's stock, valued at $2,695,113.84. This represents a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 3,298 shares of company stock worth $1,739,171 in the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Barclays decreased their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Deutsche Bank Aktiengesellschaft cut Intuitive Surgical from a "hold" rating to a "sell" rating and decreased their price objective for the company from $515.00 to $440.00 in a report on Monday, June 9th. Erste Group Bank reiterated a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday. Truist Financial boosted their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a report on Wednesday. Finally, Citigroup reaffirmed a "buy" rating and issued a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $592.05.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.